London, UK, 2023-Apr-25 — /EPR Network/ — The enormous success of our previous conference, as well as the thundering and overwhelming replies received, has cleared [read full press release…]
Northbrook, IL, USA, 2021-Dec-03 — /EPR Network/ — According to a new market research report “Parkinsons Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, [read full press release…]
Pune, India, 2021-Sep-09 — /EPR Network/ — According to a new market research report “Parkinson‘s Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel [read full press release…]
Pune, India, 2021-Aug-31 — /EPR Network/ — The Parkinsons disease treatment market is expected to reach USD 5.69 Billion by 2022 from USD 4.24 Billion [read full press release…]
Pune, India, 2021-Jul-22 — /EPR Network/ — The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at [read full press release…]
Pune, India, 2021-Jul-13 — /EPR Network/ — The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at [read full press release…]
Pune, India, 2021-May-31 — /EPR Network/ — The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at [read full press release…]
Pune, India, 2021-May-03 — /EPR Network/ — The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at [read full press release…]
Pune, India, 2021-Apr-05 — /EPR Network/ — The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at [read full press release…]
The report “Parkinsons Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) – Global [read full press release…]
The report “Parkinsons Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) – Global [read full press release…]
The report “Parkinsons Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) – Global [read full press release…]
The report “Parkinsons Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) – Global [read full press release…]
The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at a CAGR of 6.1% from 2017 to [read full press release…]
Pune, India, 2020-Feb-05 — /EPR Network/ — Parkinson’s disease treatment is used to treat the symptoms of Parkinson’s disease, generally, medication is the first line [read full press release…]
